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Pole of Magnetic Resonance
nd Intravascular Magnetic Resonance
n the Detection of Vulnerable Plaques
obert L. Wilensky, MD,* Hee Kwon Song, PHD,† Victor A. Ferrari, MD*†
hiladelphia, Pennsylvania
Noninvasive magnetic resonance imaging (MRI) has been used to determine vascular
three-dimensional structure, detect the presence of subclinical atherosclerotic disease in
high-risk patient subgroups, and optimize and follow therapy in individual patients. The
outstanding soft-tissue–characterizing capabilities of MRI permit depiction of various
components of atherothrombotic plaque, including lipid, fibrous tissue, calcium, and
thrombus formation. However, noninvasive MRI visualization of coronary arteries is
currently limited by the small size of the coronary arteries, the deep arterial location, and
arterial motion. The combination of MR imaging and molecular probes offers exciting
possibilities of direct visualization of biologic processes within atherosclerotic tissue. The
self-contained intravascular MRI probe appears to hold promise in the identification of
high-risk coronary atherosclerotic lesions with increased superficial lipid content. (J Am
ublished by Elsevier Inc. doi:10.1016/j.jacc.2005.11.048Coll Cardiol 2006;47:C48–56) © 2006 by the American College of Cardiology Foundation
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Tagnetic resonance imaging (MRI) is being increasingly
ecognized as a potential approach for the quantitation of
ascular plaque burden and assessment of lesion composi-
ion (1). An advantage of such noninvasive strategies is the
nherently lower risk afforded by avoidance of catheter
anipulation, systemic effects of contrast agents, and un-
ecessary X-ray exposure. Although angiography is an
xcellent tool to determine the degree and extent of luminal
arrowing, it cannot detect early lesion development when
uminal area is maintained by positive vascular remodeling.
his is an important limitation of angiography in that
igh-grade coronary stenoses are more likely to produce
table ischemia, but lesions with positive remodeling are
ften the lesions that cause unstable disease, such as
yocardial infarction or death. Magnetic resonance imag-
ng, on the other hand, allows for three-dimensional eval-
ation of vascular structures and outstanding depiction of
arious components of the atherothrombotic plaque, includ-
ng lipid, fibrous tissue, calcium, and thrombus formation
2). Finally, combining MRI with cellular and molecular
argeting may provide important data on the biological
ctivity of potentially vulnerable lesions (i.e., cap thickness,
ipid content, and the presence of activated macrophages,
issue factor, or integrins).
Currently, the feasibility of external field MRI to diag-
ose vulnerable plaques in coronary arteries has not been
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ccepted November 12, 2005.emonstrated, given limitations of the technique. However,
RI has been used to determine plaque size and composi-
ion in aortae and carotid arteries, and MRI-guided coro-
ary catheterization has been performed in experimental
odels (3). Accordingly, this review will describe and
ighlight the role of conventional and intravascular MRI
ethods in the assessment of morphology and plaque
ulnerability and describe the potential for novel cellular and
olecular imaging techniques to contribute additive in vivo
nformation on coronary artery plaque biology.
RI TECHNIQUES
agnetic resonance imaging essentially evaluates the dif-
erential biophysical response of the interrogated tissue to an
lectromagnetic radiofrequency (RF) pulse application
ithin a strong, static magnetic field. Application of a
agnetic field to biologic tissues leads to a net alignment of
he proton spins within the body along the direction of the
agnetic field. These protons absorb energy when a short
F pulse is applied. The RF energy is subsequently released
s the excited protons return to their original equilibrium
tate. The rate of energy release is determined by the
pin-lattice relaxation time, called T1. In addition, the spins
ephase at a specific rate determined by the spin-spin
elaxation time, measured as T2. Both the T1 and the T2
elaxation times are dependent on tissue composition and
he local spin environment. The relative contribution of T1
nd T2 in the reconstructed image can be controlled with
equence repetition time or echo time imaging parameters.
n addition, a proton-density (PD)-weighted image can be
btained by adjusting imaging parameters to reduce the T1
nd T2 contributions, leaving only the differences in water
r lipid PDs. These three different imaging contrasts (T1,
2, and PD), along with a time-of-flight (TOF) scan, are
sed to determine plaque composition. The TOF scan
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April 18, 2006:C48–56 Role of MR in Detection of Vulnerable Plaquesxploits the principle of moving blood (protons) that causes
detectable flow disturbance—even in areas of very slow
ow—and produces a three-dimensional image limited to
oving blood within vessels in an image plane.
A major challenge in high-resolution, in vivo imaging is
he achievable signal-to-noise ratio (SNR). Recent advances
n hardware, pulse sequences, and imaging approaches for
laque evaluation have improved the SNR, allowing the
ssessment of the morphology and composition of vascular
laques. Novel techniques, such as the black-blood pulse
equence and the use of phased-array receiver coils, have
een developed to improve the arterial lumen-vascular wall
ontrast critical for lesion delineation. Black-blood pulse
equence refers to suppression of the blood signal to provide
igh contrast between the lumen and the vessel wall.
lacement of multiple receiver coils circumferentially
ligned in close proximity to the artery (phased-array
eceiver coils) increases the overall detection sensitivity and,
ltimately, the image SNR. With such coil arrays, high-
esolution images of the carotid arteries (400 m and 2-
o 3-mm slice thickness) are now routinely obtained, and
ultiple scans with different contrast weightings can be
chieved with sufficient image quality.
IMITATIONS OF MRI FOR
ORONARY ARTERY IMAGING
he MRI evaluation of coronary vessels is considerably
ore difficult than imaging either carotid arteries or the
orta. As distance between the MRI coil and the interro-
ated structure increases, the SNR decreases, resulting in a
eduction in the image quality. The deep intrathoracic
osition of the coronary arteries (4 to 10 cm from the
urface) and the difficulty with optimal receiver coil place-
ent makes attaining sufficient SNR a major challenge.
eometric considerations, including the smaller dimensions
f the coronary arterial wall and the tortuous and irregular
ourse of the vessels, further exacerbate the problem, since
igher spatial resolution is required for accurate plaque
olume quantification and classification. Partial volume
ffects from relatively thick slices or large in-plane pixel
idths can cause an overestimation of the wall thickness and
esion size. Most importantly, motion effects due to cardiac
Abbreviations and Acronyms
HDL  high-density lipoprotein
IVMRI  intravascular magnetic resonance imaging
LDL  low-density lipoprotein
MRI  magnetic resonance imaging
PD  proton density
RF  radiofrequency
SNR  signal-to-noise ratio
TE-MRI  transesophageal magnetic resonance imaging
TOF  time of flight
USPIO  ultra-small particles of iron oxidend diaphragmatic motion limit the success of multi-slice seconstruction techniques, and so both respiratory and
ardiac gating are necessary to prevent motion artifacts.
cquiring the image during one or more breath-holds can
educe this limitation, although whole-heart, single breath-
old techniques have not been optimized. However, pro-
pective diaphragmatic navigator gating and real-time im-
ging (4,5) have resulted in more rapid image acquisition.
Double-inversion black-blood techniques have also been
sed for imaging coronary arteries. With dedicated phased-
rray cardiac receiver coils and further optimization of
lack-blood pulse sequences, high-resolution imaging of cor-
nary lesions may be possible (6). Higher field strength
fforded by a new generation of whole-body scanners (3-T)
ncreases the SNR and can be utilized to achieve higher spatial
esolution for improved measurement accuracy, detection sen-
itivity, or reduced scan time. An SNR improvement of 2, for
xample, could potentially be used to lower the scan time by a
actor of 4 or increase the in-plane resolution by a factor of2.
otnar et al. (7) demonstrated high-quality images of the
uman coronaries and vessel wall pathology at 3-T, while Ruff
t al. (8) have imaged mouse coronary arteries using a 7-T
agnet. Nonetheless, current techniques are limited primarily
o the major epicardial coronary arteries, and additional studies
re needed to validate the accuracy of the current strategies. In
ddition, new challenges to image quality exist at high fields,
uch as susceptibility artifacts, that ultimately limit the practi-
ality of moving to larger field systems.
ULTIPLE CONTRAST MRI
OR PLAQUE CHARACTERIZATION
he possible role of MRI for noninvasive assessment of
laque morphology and content has been demonstrated in
everal investigations (9–13). Martin et al. (9) showed that
he transverse relaxation time T2 can be used to discriminate
etween medial and adventitial layers of the arterial wall, as
ell as to detect intimal thickening at early stages of the
therosclerotic process. Toussaint et al. (10) found that
2-weighted imaging could discriminate between the col-
agenous cap and lipid core of atherosclerotic lesions. For
laque tissue characterization, a combination of TOF, PD,
nd T1- and T2-weighted scans can help determine the
resence of calcifications, necrotic cores, and recent hemor-
hage in carotid arteries (11,12) (Table 1). Figure 1 shows in
ivo images of the carotid arteries with different contrast
eightings, including TOF and T1-, T2-, and PD-weighted
lack-blood images, permitting discrimination of plaque
omponents in various stages of lesion development.
NTRAVASCULAR COILS
ne approach to interrogate deeper-lying arteries, such as
oronary arteries, is placement of an intravascular coil.
sing a custom intravascular coil, Correia et al. (13)
emonstrated that MRI results correlated well with histol-
gy and luminal area from isolated human thoracic aortic
egments. Fibrous cap recognition was observed in 20 of 24
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laques, signal property differences between fibrous cap,
ipid, and calcium has been shown ex vivo with an intravas-
ular coil (14). Currently the use of intravascular coils is
imited by the invasive nature of the diagnostic approach,
he size of the catheter, and the time-consuming imaging
rotocols. Also, an important safety issue is the potential for
ocal vessel wall heating using in vivo coils, particularly at
igh field strengths. While moving blood may dissipate
ome heating effects, small vessels such as the coronary
rteries may be more susceptible to temperature rises under
Table 1. Plaque Characterization of the Caroti
Component T1-Weighted T2-W
Hemorrhage (recent) High High
Lipid-rich necrotic core
(no hemorrhage)
Isointense-high Isoin
Calcification Low Low
Dense fibrous tissue Isointense Isoin
*Intensities are relative to that of the sternocleidomastoid mu
evaluation of carotid plaque composition by in vivo MRI. A
PD  proton density; TOF  time of flight.
igure 1. (A) A small eccentric plaque within the carotid thought to be co
oth T1- and proton density (PD)-weighted images) indicates a type III
egion of calcium deposits (Ca) indicative of a type IV to V plaque. (C) A
ignal intensity on all sequences, and no evidence of plaque rupture with a thick
ith permission, from Kampschulte et al. (12).he intense RF administration needed for full tissue char-
cterization and anatomic depiction. Hence, before these
echniques are adopted, a lack of significant vessel wall
eating must be demonstrated.
SE OF MRI TO EVALUATE
THEROSCLEROSIS PROGRESSION AND
EGRESSION AND CHANGES IN PLAQUE COMPOSITION
agnetic resonance imaging has been used to diagnose and
ollow the development of in vivo atherosclerotic lesions. In
tery Based on Multiple Contrast Weightings*
ted PD/Intermediate-Weighted TOF
High High
low Isointense-high Isointense
Low Low
Isointense Low
odified, with permission, from Saam T, et al. Quantitative
cler Thromb Vasc Biol 2005;25:1–6.
ed of fibrous tissue (FT) (dark in time of flight [TOF], moderate/high in
. (B) A carotid plaque consisting of both lipid and fibrous tissue, with a
d lesion with recent intraplaque hemorrhage (arrows) demonstrating highd Ar
eigh
tense-
tense
scle. Mmpos
plaque
carotifibrous cap surrounding the lumen (arrowhead). Figure 1C reproduced,
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April 18, 2006:C48–56 Role of MR in Detection of Vulnerable Plaquesabbits, T2-weighted MRI documented aortic lesion regression
nd a decrease in the atherosclerotic plaque lipid components
fter withdrawal of the atherosclerotic diet. In animals contin-
ed on a high-cholesterol diet, progression of disease and
ncreased lipid deposition has been observed (15,16). Regres-
ion in vessel wall thickness in an atherosclerotic rabbit model
reated with a peroxisomal proliferator-activated receptor-
amma agonist and simvastatin has also been shown (17).
Clinically, MRI can quantify and serially follow arterial
emodeling and the diffuse thickening of the coronary
rterial wall (18,19) (Fig. 2). Corti et al. (20) demonstrated
decrease in plaque size in atherosclerotic segments of the
orta and carotid artery in asymptomatic patients treated
igure 2. Double-inversion fast spin echo black-blood images of the rig
B) with fat saturation applied (inset: magnified). The vessel wall is more cl
0-s breath-hold scan using a single 3-inch surface receiver coil.
igure 3. Magnetic resonance images of a diseased rabbit abdominal aorta
anel A demonstrates diffuse and heterogeneous aortic plaque enhance
adofluorine injection. Three slice locations (1, 2, 3) were used for transve
ignal intensity vary with slice location, and reflect differing plaque com
orresponding histopathological sections, and plaque composition. In slice
has a large lipid content with corresponding well with the greatest plaque enh
 lumen; LC  lipid core; M  macrophages. Reproduced, with permissioith a statin. An increase in lumen area was seen at 18 and
4 months after therapy, secondary to decreased plaque size
nd vascular remodeling (21). Zhao et al. (22) used MRI in
case-control study of carotid disease to demonstrate that
atients treated with intensive lipid-lowering therapy and
xperiencing resulting lower low-density lipoprotein (LDL)
nd higher high-density lipoprotein (HDL) levels, had
ecreased plaque lipid content and a smaller lipid core area.
ecreased lipid plaque content has been associated with
ore stable atherosclerotic lesions. Lima et al. (23) recently
emonstrated the utility of combined surface and trans-
sophageal magnetic resonance imaging (TE-MRI) in the
ssessment of aortic plaque regression after six months of
ronary artery (arrow) in a normal subject. (A) Without fat suppression;
isible in the fat-saturated images. Each image was acquired during a single
e sagittal (A) and transverse (B) planes and corresponding histopathology.
longitudinally from the renal artery to the distal segment 24 h after
agnetic resonance images (B) and H&E staining (C). (B) Differences in
on, with greater enhancement in sections with larger lipid content. (D)
rge lipid core corresponds to greatest plaque enhancement. Plaque at levelht co
early vin th
ment
rse m
positi
2, a laancement. Ad  adventitia; F  loose fibrous tissue; FC  fibrous cap;
n, from Sirol et al. (30).
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Role of MR in Detection of Vulnerable Plaques April 18, 2006:C48–56imvastatin therapy. A 12% reduction in both plaque vol-
me and plaque area was observed, associated with a
eduction in mean LDL levels.
OLECULAR AND TARGETED CONTRAST IMAGING
n exciting area of MRI research has been the use of
oninvasive MRI techniques for molecular and targeted
ontrast imaging. These methods permit the detection of
pecific molecular markers or substances commonly found in
ulnerable plaques. Conventional (non-targeted) gadolinium-
ontaining intravenous contrast agents can improve detection
f intravascular plaque (24,25), identify plaques with increased
ascularity (26), and identify the fibrous cap in aortic
laques (27). Gadolinium-based moieties remain the only
linically approved contrast agents, although several new
erivatives are proving useful for targeted plaque imaging.
adofluorine M (Gad M) appears to have strong uptake
nd retention in the extracellular matrix of plaques (28) and
as been shown to produce enhancement in the aortic wall
f hyperlipidemic rabbits (29), a marker of lipid-rich plaque
30) (Fig. 3).
In order to image the often very small amount of
laque-related substances, contrast agents must carry a large
umber of imageable material combined with antibodies or
eptides that can bind to the target region. A number of
ovel targeted agents have been recently produced for
maging of plaque components associated with vulnerable
esions. Ultra-small particles of iron oxide (USPIOs) ad-
inistered intravenously are retained in intraplaque macro-
igure 4. (Top) A set of in vivo spin echo images was reformatted to displa
rientation is from renal artery level (left) to diaphragm (right) and at sin
v3-integrin targeted gadolinium-carrying perfluorocarbon nanoparticles. S
olor-coded signal enhancement (enhancement) above baseline (in percent) arehages (31,32). In vivo plaque imaging using these nano-
articles in humans has shown diffuse involvement within
he aorta (33), with USPIO uptake present in 75% of
uptured or vulnerable plaques but in only 7% of stable
laques. Recently, Li et al. (34) reported on a dual-labeled
ontrast agent (PTIR267) with fluorescent and gadolinium-
ased components that provided in vivo detection of LDL
eceptors. Using labeled LDL, normal livers showed signif-
cant contrast enhancement, while LDL receptor gene
nockout mice demonstrated markedly reduced enhance-
ent effect. Current studies are ongoing to evaluate whether
uch an approach can be used to determine the presence of
ascular lesions with increased LDL concentration or as a
Trojan horse” for treatment of vulnerable plaques. Recom-
inant gadolinium-labeled human HDL nanoparticles as an
ndogenous contrast agent are a novel approach to athero-
clerosis imaging. Since HDL can enter atherosclerotic
laques, no additional targeting mechanisms are necessary.
eak contrast effect—reflecting accumulation in the intimal
ayer—occurred 24 h after intravenous injection in apoE-
nockout mice, and the mean enhancement of vessel plaque
as 35% greater than surrounding muscle (35). Enhance-
ent was also related to underlying plaque composition,
ith greater enhancement in more cellular lesions. Thus,
hese new particles may permit use of endogenous biological
ransport systems to enhance plaque lipids, and perhaps to
eliver therapeutic agents in the future.
Several tissue-specific agents are in development for
RI-based applications in vulnerable plaque assessment.
ng-axis view of a diseased aorta from a hypercholesterolemic rabbit model.
ansverse slices (bottom) before (pre) and 120 min after (post) infusion ofy a lo
gle tremiautomated segmentation (segmented, grayish ring, panel 3) and
shown. Reprinted, with permission, from Winter et al. (37).
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April 18, 2006:C48–56 Role of MR in Detection of Vulnerable Plaquesissue factor expression has been imaged using a specific
agnetic resonance contrast agent (36). Tissue factor is
ormally present in the subendothelial space, but in athero-
clerosis, tissue factor has been demonstrated in virtually all
ell types within an atheroma as well as circulating leuco-
ytes. Hence, a more quantitative approach to determine
athologic tissue factor expression levels within higher risk
esions will be necessary. Another novel set of nanoparticle
gents target the v3 integrin (Fig. 4) in order to assess
ngiogenesis within plaques exhibiting neovascularization
37,38). Plaque-affected walls showed significantly greater
nhancement using targeted versus non-targeted nanopar-
icles, and enhancement has correlated well with histological
emonstration of the presence of greater v3 integrin con-
entration. Endothelial vascular cell adhesion molecule-1 ex-
ression has also been imaged with MRI (39).
Given the important role of intravascular thrombus for-
ation in acute vascular disease, a number of MR contrast
gents have been developed specifically to detect substances
ssociated with the coagulation cascade. Botnar et al. (40)
howed that molecular imaging using a fibrin-specific bind-
ng contrast agent detected acute and subacute thrombi in a
abbit atherosclerotic model. Winter et al. (41) developed a
brin-targeted, lipid-encapsulated perfluorocarbon nano-
article linked to gadolinium that binds vigorously to
hrombus and may be useful as a clinical agent, if demon-
trated in vivo. Activated platelets have been imaged using
igure 5. Apparent diffusion constants obtained by magnetic resonance f
omplex lipid-laden lesions are seen in photomicrographs. The apparent diffusio
ith overlap noted between lipid-rich and fatty streak tissue (studies performedUSPIO agent targeted to the IIb3 receptor, and Factor
IIIa has been detected using custom iron oxide particles.
hile these latter two agents can only bind to the surface of
hrombi, and therefore only create a modest contrast effect,
newer peptide that can infiltrate thrombus has been
eveloped, improving potential clinical applications (42).
ELF-CONTAINED INTRAVASCULAR MRI
ne approach to take advantage of MRI’s ability to differ-
ntiate various tissue characteristics while bypassing limita-
ions inherent in external coil MRI is a self-contained MRI
robe. Previous studies using MR have demonstrated dif-
erential water diffusion coefficients within the atheroscle-
otic plaque lipid core compared to the collageneous cap and
edial smooth-muscle layers (43). Intravascular MRI
IVMRI) makes use of these differences to determine the
xtent and location of increased vascular lipid infiltration
Fig. 5). Thin fibrous cap atheromas, considered vulnerable
esions, are thought to contain a high lipid content within
he superficial areas of the arterial wall (250 m), indi-
ating little presence of smooth-muscle cells or extracellular
atrix within the cap. Conversely, the presence of either
igh extracellular matrix content or smooth-muscle-cell rich
issue is thought to indicate the presence of a stable,
on-vulnerable lesion. This catheter offers superior spatial
esolution compared to conventional MRI. Whereas the
uman aortic samples containing normal fibrous tissue, fatty streaks, androm h
n constant shows clear difference between the fibrous and lipid-rich tissue,
in collaboration with Dr. Renu Virmani).
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rtery in a rectangular grid with an approximate 0.46-mm
lanar resolution and 2- to 5-mm slice thickness, the
VMRI obtains an image in a cylindrical-type grid with z
esolution of approximately 1.5 mm and an angular
esolution of 60° (44). The IVMRI probe provides a
adial resolution of 250 m.
ECHNICAL PROPERTIES OF THE IVMRI CATHETER
he system consists of a catheter containing an integrated
RI probe containing the magnets, RF coil, and electronics
t its tip, connected to a portable control unit. Since it has
o external magnets or coils, the system is transportable and
tudies can be performed in the cardiac catheterization
igure 6. Intravascular magnetic resonance imaging (IVMRI) results in e
nderwent interrogation with the IVMRI probe. Top row shows the lesio
he intermediate, right coronary, and left anterior descending arteries. The
he left, a stable plaque with a deep necrotic core () in the middle, and a
ow is the corresponding IVMRI results, indicating (left to right) no su
ross-section, and a TFCA with increased lipid deposition noted in three
chneiderman et al. (45).aboratory. In order to eliminate motion artifacts, a balloon, mlaced opposite the RF coil, is inflated to juxtaposition the
robe over the arterial segment in question. Two bands are
btained simultaneously, a shallow luminal band 0 to 100
m and a deeper band 100 to 250 m in depth (Fig. 6).
reliminary experiments with the MRI probe in carotid
ndarterectomy plaques demonstrated that lipid-rich tissue
ould be differentiated from fibrous tissue with a sensitivity
f 90% (J. Schneiderman, MD, unpublished results, 2001).
Proof of concept of the IVMRI catheter to analyze
ascular composition in human vascular tissues has been
hown in studies of fresh postmortem human aortas and
oronary arteries of patients dying of presumed vascular
auses (45). There was a strong correlation of the MRI data
ith histology (ulcerated plaques, thin fibrous cap athero-
human coronary arteries. Intermediate lesions on coronary angiography
postmortem angiography. The arrows point (left to right) to lesions in
le row shows the histology of these lesions, indicating a stable plaque on
brous-cap atheroma (TFCA) on the right (necrotic core, *). The bottom
tial lipid deposition, lipid deposit/necrotic core deep within the arterial
ur deep bands (yellow) and two of four superficial bands. Adapted fromx vivo
ns on
midd
thin fi
bstan
of foas, thick fibrous cap atheromas, intimal xanthomas, and
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April 18, 2006:C48–56 Role of MR in Detection of Vulnerable Plaquesdaptive intimal thickening), with a resulting 95% sensitiv-
ty and 100% specificity. Further studies were performed in
x vivo hearts with in situ coronary arteries and demon-
trated a strong correlation of the IVMRI with histology in
ntermediate arteries.
Clinical studies with the IVMRI unit have been initiated
n patients with intermediate lesions during angiographic
ssessment or concomitant percutaneous coronary interven-
ion (Fig. 7). Early results indicate that clinical evaluation of
oronary artery lipid content is feasible and safe. Future
evelopments may make use of molecular and targeted
ontrast imaging combined with IVMRI to locate the
resence of an increased concentration of macrophages
nd/or thrombus.
Currently, the evaluation of the safety and potential
linical role of the IVMRI probe is being evaluated in a
hase II international, multi-center trial. The combination
f MRI and molecular probes is being evaluated clinically,
s well. Noninvasive MRI for the evaluation of high-risk
hin fibrous cap atheromas in coronary vasculature is still in
evelopment.
eprint requests and correspondence: Dr. Robert L. Wilen-
ky, Hospital of the University of Pennsylvania, 3400 Spruce
treet, 9 Gates, Philadelphia, Pennsylvania 19104. E-mail:
obert.Wilensky@uphs.upenn.edu.
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